DEPLOYDatabase

Person

Leo Petrossian

CEO of Neurolutions, a medical device company commercializing the IpsiHand Upper Extremity Rehabilitation System, the first FDA-authorized brain-computer interface device for chronic stroke rehabilitation (De Novo market authorization granted April 2021). He led the company's commercialization of the BCI-based handpiece, which translates brain signals from the uninjured hemisphere into movement of an impaired hand.

American · 1 current role

Track Leo Petrossian

Physical AI footprint (1)

The physical AI companies Leo is connected to that DEPLOY verifies. The full record is one click away.

  • NeuroLutionsverified→
    CEO

    NeuroLutions (now merged into Kandu, Inc.) developed the [IpsiHand](/models/ipsihand) System, the first FDA-cleared brain-computer interface device for stroke r

    1 model

Current roles (1)

Sources (2)

  1. https://www.neurolutions.com/news/neurolutions-receives-fda-de-novo-market-authorization-for-ipsihand/
  2. https://www.globenewswire.com/news-release/2021/04/26/2216682/0/en/Neurolutions-Receives-U-S-Food-and-Drug-Administration-De-Novo-Market-Authorization-for-IpsiHand-Upper-Extremity-Rehabilitation-System.html

Deploy Watch

Track Leo Petrossian on Deploy.

We notify you when a verified role changes, a founded-company event lands, or litigation surfaces.